Bill Text: TX HB3707 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to value-based arrangements for prescription drugs in Medicaid.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2019-04-16 - Left pending in committee [HB3707 Detail]
Download: Texas-2019-HB3707-Introduced.html
| By: Parker | H.B. No. 3707 | |
|
|
||
|
|
||
| relating to value-based arrangements for prescription drugs in | ||
| Medicaid. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 531, Government Code, is amended by | ||
| adding Section 531.0701 to read as follows: | ||
| Sec. 531.0701. VALUE-BASED ARRANGEMENTS. Subject to | ||
| 531.071, the commission may enter into a written agreement with a | ||
| manufacturer of prescription drugs as defined by 42 U.S.C. Section | ||
| 1396r-8(k)(5) and its subsequent amendments, including a | ||
| subsidiary or affiliate of a manufacturer, based on outcomes data, | ||
| or other metrics agreed to in writing by the state and a | ||
| pharmaceutical manufacturer. Such agreements may include but not | ||
| be limited to rebates, discounts, price reductions, contributions, | ||
| risk sharing, reimbursements, deferral of payments (e.g. | ||
| installment payments), guarantees, patient care, shared savings | ||
| payments, withholds, or bonuses or anything of value. | ||
| SECTION 2. The Health and Human Services Commission shall | ||
| amend contracts with managed care plans to ensure those contracts | ||
| comply with Section 531.0701, Government Code, as added by this | ||
| Act. | ||
| SECTION 3. This Act takes effect September 1, 2019. | ||
